Evidence map›Paper›PMID 38271140›Full record

ArticleAging2024

The miR-146b-3p/TNFAIP2 axis regulates cell differentiation in acute myeloid leukaemia.

Gaochen Lan, Xiaolong Wu, Aiyue Zhao, Jinjian Lan, Qiusheng Guo, Bolin Wang, Fenglin Shen, Xiaoling Yu, Yanna Zhao, Ruilan Gao and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Diagnostic and prognostic relevance ofLeukemia research reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Gaochen LanDepartment of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Xiaolong WuCollege of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
Aiyue ZhaoDepartment of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Jinjian LanThe First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
Qiusheng GuoDepartment of Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Bolin WangInstitute of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Fenglin ShenThe First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
Xiaoling YuInstitute of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Yanna ZhaoInstitute of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Ruilan GaoInstitute of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Tianwen XuDepartment of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Zhejiang Chinese Medical University · CNFujian Medical University · CNSecond Affiliated Hospital of Fujian Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our purpose is to verify that miR-146b-3p targets the downstream transcript TNFAIP2 in order to reveal the machinery underlying the miR-146b-3p/TNFAIP2 axis regulating acute myeloid leukaemia (AML) differentiation. Bioinformatics analyses were performed using multiple databases and R packages. The CD11b+ and CD14+ cell frequencies were detected using flow cytometry and immunofluorescence staining. The TNFAIP2 protein expression was evaluated using western blotting, immunocytochemistry and immunofluorescence staining. The qRT-PCR was conducted to detect the expression of TNFAIP2 and miR-146b-3p. TNFAIP2 and its correlated genes were enriched in multiple cell differentiation pathways. TNFAIP2 was upregulated upon leukaemic cell differentiation. miR-146b-3p directly targeted TNFAIP2, resulting in a decrease in TNFAIP2 expression. Forced expression of TNFAIP2 or knockdown of miR-146b-3p significantly induced the differentiation of MOLM-13 cells. In this study, we demonstrated that TNFAIP2 is a critical driver in inducing differentiation and that the miR-146b-3p/TNFAIP2 axis involves in regulating cell differentiation in AML.

Indexed as

CytokinesLeukemia, Myeloid, AcuteMicroRNAsApoptosisCell DifferentiationCell ProliferationHumansCytokinesMicroRNAsMIRN146 microRNA, humanTNFAIP2 protein, humanAMLdifferentiationmechanismmiR-146b-3pTNFAIP2

Identifiers

PMID38271140
PMCPMC10866442
OpenAlexW4391263809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.